[Hereditary angioneurotic edema in children]

H Farkas1, G Harmat, G Füst

  • 1Altalános Orvostudományi Kar Kútvölgyi Igazgatóság, Fül-orr-gégészeti, Allergológiai és Angiooedema Szakrendelés, Semmelweis Egyetem, Budapest.

Orvosi Hetilap
|January 6, 2001
PubMed

Insights

Hereditary angioneurotic edema (HAE) is caused by C1-esterase inhibitor deficiency. Effective prophylaxis and treatment, including C1-inhibitor concentrate, significantly reduce HAE attacks and improve pediatric patients' quality of life.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Context:

  • Hereditary angioneurotic edema (HAE) is an autosomal dominant disorder.
  • It stems from a deficiency in C1-esterase inhibitor.
  • Characterized by recurrent swelling in the subcutis and submucosa.

Purpose:

  • To review clinical records of 21 children with HAE.
  • To evaluate the effectiveness of prophylaxis and treatment strategies.
  • To assess the role of abdominal ultrasonography in HAE management.

Summary:

  • Clinical manifestations typically begin between 2.5 and 12 years of age, with mechanical trauma as a common trigger.
  • Long-term prophylaxis with tranexamic acid and danazol, and short-term prophylaxis were administered.
  • C1-inhibitor concentrate effectively resolved acute attacks, and abdominal ultrasonography revealed transient ascites.
  • Therapy improved serum complement levels and reduced attack frequency and severity.

Impact:

  • Adequate prophylaxis and follow-up care can prevent edematous attacks in pediatric patients.
  • Optimizing drug dosage minimizes adverse effects and enhances patient quality of life.
  • This study highlights the importance of comprehensive management for HAE in children.

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...